QDEL · NASDAQ · Medical - Specialties

QuidelOrtho (QDEL)

Runs hospital lab instruments and point-of-care rapid tests under one roof.

$10.74
vs last close−0.20 (−1.80%)

In millions of USD, except per-share figures

In millionsQ3 FY23Oct 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue744743711637727708693614700724620631
Cost of revenue375361379361375382350339364403356358
Gross profit369381332276352326343275336320264273
3433412,0903943374273114561,040387291295
Research & development625959565647534642464549
194188205188186188187178187194199190
Selling & marketing000006000000
General & administrative00000181000000
Other expenses88941,82614995192712328121474756
Operating income2640−1,758−11815−10033−181−705−66−27−22
−42−49−41−45−44−41−41−49−52−46−52−59
Interest income010101030310
Interest expense294632485045424646435155
Other non-operating income−53−5−2−6−4−164345
Income before tax−16−9−1,799−163−29−141−9−230−757−112−80−81
Income tax expense−3−16−93−15−938426−24181212
Net income from continuing operations−137−1,706−148−20−178−13−255−733−131−92−93
Net income−137−1,706−148−20−178−13−255−733−131−92−93
EPS, basic−$0.19$0.10−$25.50−$2.20−$0.30−$2.28−$0.19−$3.77−$10.78−$1.95−$1.35−$1.36
EPS, diluted−$0.19$0.10−$25.50−$2.20−$0.30−$2.28−$0.19−$3.77−$10.78−$1.95−$1.35−$1.36
Weighted average shares, basic676767676767686868686868
Weighted average shares, diluted676767676767686868686868
EBITDA144152−1,638113413141−76−5974381−27
Depreciation & amortization1131151151161131091071101121131130
EBIT3137−1,753−11521−9634−187−709−69−32−27